14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

NBRV Predictions History

4 years ago
Oskari Mäkinen predicted that NBRV for 2020-02-18 is going

Rank:

4 years ago
Edgardo Zambrao predicted that NBRV for 2020-02-18 is going $1.55 (-90.00%)

Rank:

4 years ago
JS predicted that NBRV for 2020-02-18 is going $1.58 (-89.81%)

4 years ago
long predicted that NBRV for 2019-08-29 is going $2.44 (-88.38%)

Rank:

5 years ago
NameNotImportant predicted that NBRV for 2019-05-06 is going $2.17 (-90.31%)

5 years ago
NameNotImportant predicted that NBRV for 2019-05-02 is going $2.72 (-87.35%)

5 years ago
Colek77 predicted that NBRV for 2019-05-01 is going $3.07 (-89.73%)

Rank:

5 years ago
NameNotImportant predicted that NBRV for 2019-04-24 is going $2.79 (-90.28%)

5 years ago
Kyle.Van.Beek.108740 predicted that NBRV for 2019-04-24 is going $3.09 (-89.23%)

Rank:

5 years ago
Rantsun19 predicted that NBRV for 2019-04-23 is going $4.30 (-84.97%)

Rank:
Click to get the best stock tips daily for free!

About Nabriva Therapeutics AG

Nabriva Therapeutics AG Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia. It also dev... NBRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT